The DOI matches its Crossref record; 531 of the 531 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
Open accessAbstract
is a prototypical GPCR for the development of peptide-based radiopharmaceuticals for diagnostic and therapeutic interventions. This review article summarizes findings published in the last 25 years on the physiology, pharmacology, and clinical applications related to SSTs. We also discuss potential future developments and propose a new nomenclature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., & Guillemin, R. (1973) · Science · doi:10.1126/science.179.4068.77 · Cited by 3,532
Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors
Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607427 · Cited by 3,308
Rinke, A., Müller, H.-H., Schade-Brittinger, C., Klose, K.-J., Barth, P., Wied, M., Mayer, C., Aminossadati, B., Pape, U.-F., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,508
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Caplin, M. E., Pavel, M., Ćwikła, J. B., Phan, A. T., Raderer, M., Sedláčková, E., Cadiot, G., Wolin, E. M., Capdevila, J., Wall, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316158 · Cited by 1,935
Acromegaly: An Endocrine Society Clinical Practice Guideline
Katznelson, L., Laws, E. R., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2700 · Cited by 1,786
Self-citationSomatostatin and Its Receptor Family
Patel, Y. C. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., Petcher, T. J., & Pless, J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90087-x · Cited by 1,331
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
G-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,166
Pavel, M. E., Hainsworth, J. D., Baudin, E., Peeters, M., Hörsch, D., Winkler, R. E., Klimovsky, J., Lebwohl, D., Jehl, V., Wolin, E. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61742-x · Cited by 1,058
Reichlin, S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312153092406 · Cited by 1,044
Lamberts, S. W. J., van der Lely, A.-J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 1,001
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000) · Science · doi:10.1126/science.288.5463.154 · Cited by 888
Oakley, R. H., Laporte, S. A., Holt, J. A., Caron, M. G., & Barak, L. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910348199 · Cited by 882
Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement
Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2734 · Cited by 853
Self-citationOkazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., & Honjo, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231486598 · Cited by 848
Direct Stimulation of the Guanine Nucleotide Exchange Activity of p115 RhoGEF by Gα 13
Hart, M. J., Jiang, X., Kozasa, T., Roscoe, W., Singer, W. D., Gilman, A. G., Sternweis, P. C., & Bollag, G. (1998) · Science · doi:10.1126/science.280.5372.2112 · Cited by 779
Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I., & Seino, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.251 · Cited by 753
Sexual Dimorphism in the Control of Growth Hormone Secretion*
JANSSON, J.-O., EDÉN, S., & ISAKSSON, O. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-2-128 · Cited by 745
Imaging Dopamine Receptors in the Human Brain by Positron Tomography
Wagner, H. N., Burns, H. D., Dannals, R. F., Wong, D. F., Langstrom, B., Duelfer, T., Frost, J. J., Ravert, H. T., Links, J. M., Rosenbloom, S. B., et al. (1983) · Science · doi:10.1126/science.6604315 · Cited by 741
Bruns, C., Lewis, I., Briner, U., Meno-Tetang, G., & Weckbecker, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460707 · Cited by 692
Johansson, O., Hökfelt, T., & Elde, R. P. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90233-1 · Cited by 674
Reubi, J., Waser, B., Schaer, J.-C., & Laissue, J. A. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100541 · Cited by 657
Selective Amplification And Cloning Of Four New Members Of The G Protein-coupled Receptor Family
Libert, F., Parmentier, M., Lefort, A., Dinsart, C., Van Sande, J., Maenhaut, C., Simons, M.-J., Dumont, J. E., & Vassart, G. (1989) · Science · doi:10.1126/science.2541503 · Cited by 641
Neuroendocrine Control of Growth Hormone Secretion
Müller, E. E., Locatelli, V., & Cocchi, D. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.511 · Cited by 634
A 12-month phase 3 study of pasireotide in Cushing's disease
Colao, A., Petersenn, S., Newell-Price, J., Findling, J. W., Gu, F., Maldonado, M., Schoenherr, U., Dipl.-Biol., Mills, D., Salgado, L. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105743 · Cited by 628
LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
Krenning, E. P., Breeman, W. A. P., Kooij, P. P. M., Lameris, J. S., Bakker, W. H., Koper, J. W., Ausema, L., Reubi, J. C., & Lamberts, S. W. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91258-0 · Cited by 625
Molecular Biology of Somatostatin Receptors*
REISINE, T., & BELL, G. I. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-427 · Cited by 618
Jin, H., White, S. R., Shida, T., Schulz, S., Aguiar, M., Gygi, S. P., Bazan, J. F., & Nachury, M. V. (2010) · Cell · doi:10.1016/j.cell.2010.05.015 · Cited by 605
Self-citationTHE CONCISE GUIDE TO PHARMACOLOGY 2017/18: g protein-coupled receptors
Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Marrion, N. V., Peters, J. A., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13878 · Cited by 588
Reichlin, S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312223092506 · Cited by 577
Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors
Calebiro, D., Nikolaev, V. O., Gagliani, M. C., de Filippis, T., Dees, C., Tacchetti, C., Persani, L., & Lohse, M. J. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000172 · Cited by 574
Classification and nomenclature of somatostatin receptors
Hoyer, D., Bell, G. I., Berelowitz, M., Epelbaum, J., Feniuk, W., Humphrey, P. P. A., O'Carroll, A.-M., Patel, Y. C., Schonbrunn, A., Taylor, J. E., et al. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88988-9 · Cited by 570
Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers
Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., & Patel, Y. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7862 · Cited by 527
N‐terminally extended somatostatin: The primary structure of somatostatin‐28
Pradayrol, L., Jörnvall, H., Mutt, V., & Ribet, A. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)81310-x · Cited by 526
Steinberg, F., Gallon, M., Winfield, M., Thomas, E. C., Bell, A. J., Heesom, K. J., Tavaré, J. M., & Cullen, P. J. (2013) · Nature Cell Biology · doi:10.1038/ncb2721 · Cited by 524
Ginj, M., Zhang, H., Waser, B., Cescato, R., Wild, D., Wang, X., Erchegyi, J., Rivier, J., Mäcke, H. R., & Reubi, J. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607761103 · Cited by 515
Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives
Simó, R., & Hernández, C. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.09.005 · Cited by 490
Smale, S. T., Schmidt, M. C., Berk, A. J., & Baltimore, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4509 · Cited by 481
Berbari, N. F., Lewis, J. S., Bishop, G. A., Askwith, C. C., & Mykytyn, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711027105 · Cited by 474
The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance
Hofland, L. J., & Lamberts, S. W. J. (2003) · Endocrine Reviews · doi:10.1210/er.2000-0001 · Cited by 474
Rohrer, S. P., Birzin, E. T., Mosley, R. T., Berk, S. C., Hutchins, S. M., Shen, D.-M., Xiong, Y., Hayes, E. C., Parmar, R. M., Foor, F., et al. (1998) · Science · doi:10.1126/science.282.5389.737 · Cited by 458
Mechanisms for pituitary tumorigenesis: the plastic pituitary
Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320401 · Cited by 456
Self-citationPOU-domain transcription factors: pou-er-ful developmental regulators.
Rosenfeld, M. G. (1991) · Genes & Development · doi:10.1101/gad.5.6.897 · Cited by 447
Valkema, R., de Jong, M., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Lugtenburg, P. J., de Jong, F. H., Christiansen, A., Kam, B. L. R., de Herder, W. W., et al. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc/2002.31025 · Cited by 435
Krenning, E. P., Bakker, W., Kooij, P. P. M., Breeman, W. A., Oei, H. Y., de Jong, M., Reubi, J. C., Visser, T. J., Bruns, C., & Kwekkeboom, D. J. (1992) · PubMed · Cited by 420
A cortical neuropeptide with neuronal depressant and sleep-modulating properties
de Lecea, L., Criado, J. R., Prospero-Garcia, Ó., Gautvik, K. M., Schweitzer, P., Danielson, P. E., Dunlop, C. L. M., Siggins, G. R., Henriksen, S. J., & Sutcliffe, J. G. (1996) · Nature · doi:10.1038/381242a0 · Cited by 416
Somatostatin receptors: From signaling to clinical practice
Theodoropoulou, M., & Stalla, G. K. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.07.005 · Cited by 410
Expert consensus document: A consensus on the medical treatment of acromegaly
Giustina, A., Chanson, P., Kleinberg, D., Bronstein, M. D., Clemmons, D. R., Klibanski, A., van der Lely, A. J., Strasburger, C. J., Lamberts, S. W., Ho, K. K. Y., et al. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.21 · Cited by 407
Self-citationPasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
Colao, A., Bronstein, M. D., Freda, P., Gu, F., Shen, C.-C., Gadelha, M., Fleseriu, M., van der Lely, A. J., Farrall, A. J., Hermosillo Reséndiz, K., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2480 · Cited by 400
Waldherr, C., Pless, M., Maecke, H. R., Haldemann, A., & Mueller-Brand, J. (2001) · Annals of Oncology · doi:10.1023/a:1011160913619 · Cited by 396
Gadelha, M. R., Bronstein, M. D., Brue, T., Coculescu, M., Fleseriu, M., Guitelman, M., Pronin, V., Raverot, G., Shimon, I., Lievre, K. K., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70169-x · Cited by 396
Antunes, P., Ginj, M., Zhang, H., Waser, B., Baum, R. P., Reubi, J. C., & Maecke, H. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0317-x · Cited by 393
Kim, Y., Yang, G. R., Pradhan, K., Venkataraju, K. U., Bota, M., García del Molino, L. C., Fitzgerald, G., Ram, K., He, M., Levine, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.020 · Cited by 389
Rubin, J., Ajani, J., Schirmer, W., Venook, A. P., Bukowski, R., Pommier, R., Saltz, L., Dandona, P., & Anthony, L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.600 · Cited by 389
Selective targeting of somatostatin receptor 3 to neuronal cilia
Händel, M., Schulz, S., Stanarius, A., Schreff, M., Erdtmann-Vourliotis, M., Schmidt, H., Wolf, G., & Höllt, V (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00354-6 · Cited by 386
Self-citationDaly, A. F., Tichomirowa, M. A., Petrossians, P., Heliövaara, E., Jaffrain-Rea, M.-L., Barlier, A., Naves, L. A., Ebeling, T., Karhu, A., Raappana, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2556 · Cited by 384
Somatostatin-expressing neurons in cortical networks
Urban-Ciecko, J., & Barth, A. L. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.53 · Cited by 374
Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
Mullershausen, F., Zecri, F., Cetin, C., Billich, A., Guerini, D., & Seuwen, K. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.173 · Cited by 370
An Actin Network Dispatches Ciliary GPCRs into Extracellular Vesicles to Modulate Signaling
Nager, A. R., Goldstein, J. S., Herranz-Pérez, V., Portran, D., Ye, F., Garcia-Verdugo, J. M., & Nachury, M. V. (2017) · Cell · doi:10.1016/j.cell.2016.11.036 · Cited by 366
Berbari, N. F., Johnson, A. D., Lewis, J. S., Askwith, C. C., & Mykytyn, K. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-09-0942 · Cited by 364
Strowski, M. Z. (2000) · Endocrinology · doi:10.1210/en.141.1.111 · Cited by 359
Long-Acting Somatostatin Analog Therapy of Acromegaly: A Meta-Analysis
Freda, P. U., Katznelson, L., van der Lely, A. J., Reyes, C. M., Zhao, S., & Rabinowitz, D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0260 · Cited by 346
Long-range-projecting GABAergic neurons modulate inhibition in hippocampus and entorhinal cortex
Melzer, S., Michael, M., Caputi, A., Eliava, M., Fuchs, E. C., Whittington, M. A., & Monyer, H. (2012) · Science · doi:10.1126/science.1217139 · Cited by 333
Fee, C., Banasr, M., & Sibille, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.024 · Cited by 329
Bakker, W. H., Albert, R., Bruns, C., Breeman, W. A. P., Hofland, L. J., Marbach, P., Pless, J., Pralet, D., Stolz, B., Koper, J. W., et al. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90052-d · Cited by 328
Buscail, L., Delesque, N., Estève, J. P., Saint-Laurent, N., Prats, H., Clerc, P., Robberecht, P., Bell, G. I., Liebow, C., & Schally, A. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2315 · Cited by 327
Homo- and Heterodimerization of Somatostatin Receptor Subtypes
Pfeiffer, M., Koch, T., Schröder, H., Klutzny, M., Kirscht, S., Kreienkamp, H., Höllt, V., & Schulz, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006084200 · Cited by 319
Self-citationRegulation and function of somatostatin receptors
Olias, G., Viollet, C., Kusserow, H., Epelbaum, J., & Meyerhof, W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02402.x · Cited by 318
Wild, D., Schmitt, J. S., Ginj, M., Mäcke, H. R., Bernard, B. F., Krenning, E., de Jong, M., Wenger, S., & Reubi, J.-C. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1255-5 · Cited by 310
Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase.
Yasuda, K., Rens-Domiano, S., Breder, C. D., Law, S. F., Saper, C. B., Reisine, T., & Bell, G. I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88719-7 · Cited by 309
Shimon, I., Taylor, J. E., Dong, J. Z., Bitonte, R. A., Kim, S., Morgan, B., Coy, D. H., Culler, M. D., & Melmed, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119225 · Cited by 309
Self-citationMøller, L. N., Stidsen, C. E., Hartmann, B., & Holst, J. J. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00235-9 · Cited by 307
Leontiou, C. A., Gueorguiev, M., van der Spuy, J., Quinton, R., Lolli, F., Hassan, S., Chahal, H. S., Igreja, S. C., Jordan, S., Rowe, J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2611 · Cited by 299
Self-citationYamada, Y. (1992) · Molecular Endocrinology · doi:10.1210/me.6.12.2136 · Cited by 294
Molecular cloning and functional expression of a brain-specific somatostatin receptor.
Bruno, J. F., Xu, Y., Song, J., & Berelowitz, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11151 · Cited by 294
Pasireotide (SOM230): Development, mechanism of action and potential applications
Schmid, H. A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.09.006 · Cited by 290 · cited 1×
“The only clinically approved SRIF analog showing high affinity for SST1 is pasireotide, a nonselective peptidic compound displaying an IC50 of 9.3 nM for SST1, and IC50 values for SST2, SST3, and SST5 of 1, 1.5, and 0.16 nM, respectively (Schmid, 2008).”
BackgroundInfluentialBarone, R., Borson‐Chazot, F., Valkema, R., Walrand, S., Chauvin, F., Gogou, L., Kvols, L. K., Krenning, E. P., Jamar, F., & Pauwels, S. A. (2005) · PubMed · Cited by 289
Beck-Peccoz, P., Lania, A., Beckers, A., Chatterjee, K., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000351007 · Cited by 283
Raynor, K., Murphy, W. A., Coy, D. H., Taylor, J. E., Moreau, J. P., Yasuda, K., Bell, G. I., & Reisine, T. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13664-x · Cited by 280
Hofland, L. J., van der Hoek, J., Feelders, R., van Aken, M. O., van Koetsveld, P. M., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., de Herder, W. W., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01876 · Cited by 276
O'Carroll, A. M., Lolait, S. J., König, M., & Mahan, L. C. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09269-7 · Cited by 274
The neurobiology of somatostatin.
Epelbaum, J., Dournaud, P., Fodor, M., & Viollet, C. (1994) · PubMed · Cited by 270
Self-citationCloning and expression of a novel mouse somatostatin receptor (SSTR2B)
Vanetti, M., Kouba, M., Wang, X., Vogt, G., & Höllt, V. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81122-3 · Cited by 269
Sharma, K. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1688 · Cited by 269
LAMBERTS, S. W. J. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-4-417 · Cited by 265
Pfeiffer, M., Koch, T., Schröder, H., Laugsch, M., Höllt, V., & Schulz, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110373200 · Cited by 263
Self-citationTissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat
Bruno, J. F. (1993) · Endocrinology · doi:10.1210/en.133.6.2561 · Cited by 261
Somatostatin stimulates Ca2+-activated K+ channels through protein dephosphorylation
White, R. E., Schonbrunn, A., & Armstrong, D. L. (1991) · Nature · doi:10.1038/351570a0 · Cited by 260
Shimon, I., Yan, X., Taylor, J. E., Weiss, M. H., Culler, M. D., & Melmed, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119779 · Cited by 260
Self-citationCellular biology of somatostatin receptors
Csaba, Z., & Dournaud, P. (2001) · Neuropeptides · doi:10.1054/npep.2001.0848 · Cited by 250
Self-citationYamada, Y., Kagimoto, S., Kubota, A., Yasuda, K., Masuda, K., Someya, Y., Ihara, Y., Li, Q., Imura, H., Seino, S., et al. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2122 · Cited by 248
Kamenický, P., Mazziotti, G., Lombès, M., Giustina, A., & Chanson, P. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1071 · Cited by 245
All Five Cloned Human Somatostatin Receptors (hSSTR1-5) Are Functionally Coupled to Adenylyl Cyclase
Patel, Y. C., Greenwood, M. T., Warszynska, A., Panetta, R., & Srikant, C. B. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1088 · Cited by 239
Brain renin-angiotensin—A new look at an old system
Wright, J. W., & Harding, J. W. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.07.001 · Cited by 233
NHE1 promotes invadopodial ECM proteolysis through acidification of the peri‐invadopodial space
Busco, G., Cardone, R. A., Greco, M. R., Bellizzi, A., Colella, M., Antelmi, E., Mancini, M. T., Dell'Aquila, M. E., Casavola, V., Paradiso, A., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-149518 · Cited by 229
Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
Mazziotti, G., Floriani, I., Bonadonna, S., Torri, V., Chanson, P., & Giustina, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2332 · Cited by 227
Breeman, W. A., de Jong, M., Kwekkeboom, D. J., Valkema, R., Bakker, W. H., Kooij, P. P., Visser, T. J., & Krenning, E. P. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100502 · Cited by 226
DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy
Otte, A., Jermann, E., Behe, M., Goetze, M., Bucher, H. C., Roser, H. W., Heppeler, A., Mueller-Brand, J., & Maecke, H. R. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00879669 · Cited by 224
Inhibitory effect of somatostatin on inflammation and nociception
Pintér, E., Helyes, Z., & Szolcsányi, J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.010 · Cited by 223
Theodoropoulou, M., Zhang, J., Laupheimer, S., Paez-Pereda, M., Erneux, C., Florio, T., Pagotto, U., & Stalla, G. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1189 · Cited by 216
Somatostatin Augments the M-Current in Hippocampal Neurons
Moore, S. D., Madamba, S. G., Joëls, M., & Siggins, G. R. (1988) · Science · doi:10.1126/science.2892268 · Cited by 214
Duluc, C., Moatassim‐Billah, S., Chalabi‐Dchar, M., Perraud, A., Samain, R., Breibach, F., Gayral, M., Cordelier, P., Delisle, M., Bousquet‐Dubouch, M., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404346 · Cited by 214
Self-citationMurray, R. D., & Melmed, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0027 · Cited by 214
Self-citationPituitary somatostatin receptor signaling
Ben-Shlomo, A., & Melmed, S. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.12.003 · Cited by 213
Self-citationPrimary structure of ovine hypothalamic somatostatin-28 and somatostatin-25.
Esch, F., Böhlen, P., Ling, N., Benoit, R., Brazeau, P., & Guillemin, R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6827 · Cited by 209
Kulaksiz, H., Eissele, R., Rössler, D., Schulz, S., Höllt, V, Cetin, Y., & Arnold, R. (2002) · Gut · doi:10.1136/gut.50.1.52 · Cited by 209
Self-citationG Protein Activation of a Hormone-Stimulated Phosphatase in Human Tumor Cells
Pan, M. G., Florio, T., & Stork, P. J. S. (1992) · Science · doi:10.1126/science.256.5060.1215 · Cited by 205
Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
Buscail, L., Saint‐Laurent, N., Chastre, E., Vaillant, J., Gespach, C. P., Capellá, G., Kalthoff, H., Lluı́s, F., Vaysse, N., & Susini, C. (1996) · PubMed · Cited by 201
Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
Giustina, A., Mazziotti, G., Torri, V., Spinello, M., Floriani, I., & Melmed, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036411 · Cited by 201
Self-citationBatista, D. L., Zhang, X., Gejman, R., Ansell, P. J., Zhou, Y., Johnson, S. A., Swearingen, B., Hedley-Whyte, E. T., Stratakis, C. A., & Klibanski, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1245 · Cited by 201
Expression cloning of a rat brain somatostatin receptor cDNA.
Kluxen, F. W., Bruns, C., & Lübbert, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4618 · Cited by 198
Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions
Spier, A. D., & de Lecea, L. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00031-x · Cited by 197
Wild, D., Mäcke, H. R., Waser, B., Reubi, J. C., Ginj, M., Rasch, H., Müller-Brand, J., & Hofmann, M. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1697-4 · Cited by 192
Somatostatinergic systems in brain: Networks and functions
Viollet, C., Lepousez, G., Loudes, C., Videau, C., Simon, A., & Epelbaum, J. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.09.007 · Cited by 191
Greenman, Y. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.3.724 · Cited by 190
Baraban, S. C., & Tallent, M. K. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.01.008 · Cited by 187
Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors
Panetta, R., & Patel, Y. C. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00956-2 · Cited by 185
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
Cescato, R., Schulz, S., Waser, B., Eltschinger, V., Rivier, J., Wester, H.-J., Culler, M. D., Ginj, M., Liu, Q., Schönbrunn, A., et al. (2006) · PubMed · Cited by 183
Self-citationFirst Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible
Wild, D., Fani, M., Behe, M., Brink, I., Rivier, J. E. F., Reubi, J. C., Maecke, H. R., & Weber, W. A. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.088922 · Cited by 183
Caron, P. J., Bevan, J. S., Petersenn, S., Flanagan, D., Tabarin, A., Prévost, G., Maisonobe, P., Clermont, A., & on behalf of the PRIMARYS Investigators (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3318 · Cited by 182
Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors
Greenman, Y. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.398 · Cited by 180
H., W., M., S., K., S., G., M., M., H., F., R., J., R., & M., S. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1012-1 · Cited by 177
Dalm, V. A. S. H., van Hagen, P. M., van Koetsveld, P. M., Achilefu, S., Houtsmuller, A. B., Pols, D. H. J., van der Lely, A.-J., Lamberts, S. W. J., & Hofland, L. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00048.2003 · Cited by 177
Sandostatin LAR in Acromegalic Patients: Long Term Treatment
Fløgstad, A. K., Halse, J., Bakke, S. J., Lancranjan, I., Marbach, P., Bruns, C., & Jervell, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3572 · Cited by 176
Bakker, W. H., Krenning, E. P., Reubi, J.-C., Breeman, W. A. P., Setyono-Han, B., de Jong, M., Kooij, P. P. M., Bruns, C., van Hagen, P. M., Marbach, P., et al. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90053-e · Cited by 174
Carmichael, J. D., Bonert, V. S., Nuño, M., Ly, D., & Melmed, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3757 · Cited by 174
Self-citationArachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current
Schweitzer, P., Madamba, S., & Siggins, G. R. (1990) · Nature · doi:10.1038/346464a0 · Cited by 173
Righi, L., Volante, M., Tavaglione, V., Billè, A., Daniele, L., Angusti, T., Inzani, F., Pelosi, G., Rindi, G., & Papotti, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp334 · Cited by 173
Unexpected Sensitivity of sst2 Antagonists to N-Terminal Radiometal Modifications
Fani, M., Braun, F., Waser, B., Beetschen, K., Cescato, R., Erchegyi, J., Rivier, J. E., Weber, W. A., Maecke, H. R., & Reubi, J. C. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.102764 · Cited by 172
Differential β-Arrestin Trafficking and Endosomal Sorting of Somatostatin Receptor Subtypes
Tulipano, G., Stumm, R., Pfeiffer, M., Kreienkamp, H.-J., Höllt, V., & Schulz, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313522200 · Cited by 172
Self-citationLesche, S., Lehmann, D., Nagel, F., Schmid, H. A., & Schulz, S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1919 · Cited by 172
Self-citationNicolas, G. P., Schreiter, N., Kaul, F., Uiters, J., Bouterfa, H., Kaufmann, J., Erlanger, T. E., Cathomas, R., Christ, E., Fani, M., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.199760 · Cited by 171
Zheng, H., Bailey, A., Jiang, M.-H., Honda, K., Chen, H. Y., Trumbauer, M. E., Van der Ploeg, L. H. T., Schaeffer, J. M., Leng, G., & Smith, R. G. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.11.0016 · Cited by 169
Gabriel, M., Decristoforo, C., Donnemiller, E., Ulmer, H., Rychlinski, C. W., Mather, S. J., & Moncayo, R. (2003) · PubMed · Cited by 169
Therapeutic uses of somatostatin and its analogues: Current view and potential applications
Rai, U., Thrimawithana, T. R., Valery, C., & Young, S. A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.007 · Cited by 168
Hukovic, N. (1996) · Endocrinology · doi:10.1210/en.137.9.4046 · Cited by 168
Saveanu, A., Gunz, G., Dufour, H., Caron, P., Fina, F., Ouafik, L., Culler, M. D., Moreau, J. P., Enjalbert, A., & Jaquet, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7099 · Cited by 168
Self-citationResults of a European Multicentre Study with Sandostatin® LAR® in Acromegalic Patients
Lancranjan, I., Atkinson, A. B., & Sandostatin® LAR® Group# (1999) · Pituitary · doi:10.1023/a:1009980404404 · Cited by 166
Neuropeptides in learning and memory
Borbély, É., Scheich, B., & Helyes, Z. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.012 · Cited by 166
SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells
Kailey, B., van de Bunt, M., Cheley, S., Johnson, P. R., MacDonald, P. E., Gloyn, A. L., Rorsman, P., & Braun, M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00207.2012 · Cited by 164
Low, M. J., Otero-Corchon, V., Parlow, A. F., Ramirez, J. L., Kumar, U., Patel, Y. C., & Rubinstein, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11941 · Cited by 163
Localization of the Somatostatin Receptor SST2Ain Rat Brain Using a Specific Anti-Peptide Antibody
Dournaud, P., Gu, Y. Z., Schonbrunn, A., Mazella, J., Tannenbaum, G. S., & Beaudet, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04468.1996 · Cited by 163
Self-citationWeckbecker, G., Briner, U., Lewis, I., & Bruns, C. (2002) · Endocrinology · doi:10.1210/en.2002-220219 · Cited by 163
Hayashi, K., Inoshita, N., Kawaguchi, K., Ibrahim Ardisasmita, A., Suzuki, H., Fukuhara, N., Okada, M., Nishioka, H., Takeuchi, Y., Komada, M., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0689 · Cited by 162
Primary structure of the gene encoding rat preprosomatostatin.
Montminy, M. R., Goodman, R. H., Horovitch, S. J., & Habener, J. F. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3337 · Cited by 161
Schulz, S., Händel, M., Schreff, M., Schmidt, H., & Höllt, V. (2000) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(00)00212-6 · Cited by 157
Self-citationCortistatin Is Expressed in a Distinct Subset of Cortical Interneurons
de Lecea, L., del Río, J. A., Criado, J. R., Alcántara, S., Morales, M., Danielson, P. E., Henriksen, S. J., Soriano, E., & Sutcliffe, J. G. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05868.1997 · Cited by 157
Gi alpha 3 and G(o) alpha selectively associate with the cloned somatostatin receptor subtype SSTR2
Law, S. F., Yasuda, K., Bell, G. I., & Reisine, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82045-2 · Cited by 153
Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives
Conlon, J. M., Tostivint, H., & Vaudry, H. (1997) · Regulatory Peptides · doi:10.1016/s0167-0115(97)02135-6 · Cited by 153
Novel pathway for somatostatin analogs in patients with acromegaly
Gadelha, M. R., Kasuki, L., & Korbonits, M. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.11.007 · Cited by 153
Self-citationMeyerhof, W., Wulfsen, I., Schönrock, C., Fehr, S., & Richter, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10267 · Cited by 152
Schindler, M., Sellers, L. A., Humphrey, P. P. A., & Emson, P. C. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00388-0 · Cited by 150
Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
Chahal, H., Trivellin, G., Leontiou, C. A., Alband, N., Fowkes, R. C., Tahir, A., Igreja, S., Chapple, J. P., Jordan, S., Lupp, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1111 · Cited by 149
Self-citationNicolas, G. P., Mansi, R., McDougall, L., Kaufmann, J., Bouterfa, H., Wild, D., & Fani, M. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.191684 · Cited by 149
Identification and characterization of novel somatostatin antagonists.
Bass, R. T., Buckwalter, B. L., Patel, B. P., Pausch, M. H., Price, L. A., Strnad, J., & Hadcock, J. R. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09370-8 · Cited by 148
Therapeutic Options for Gastrointestinal Carcinoids
Modlin, I. M., Latich, I., Kidd, M. S., Zikusoka, M. N., & Eick, G. N. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.008 · Cited by 148
Pharmacology and Signaling of MAS-Related G Protein–Coupled Receptors
Solinski, H. J., Gudermann, T. W., & Breit, A. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008425 · Cited by 148
Armani, C., Catalani, E., Balbarini, A., Bagnoli, P., & Cervia, D. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606417 · Cited by 145
Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia
González‐Rey, E., Chorny, A., Robledo, G., & Delgado, M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052017 · Cited by 142
Somatostatin Activation of Mitogen-Activated Protein Kinase via Somatostatin Receptor 1 (SSTR1)
Florio, T., Yao, H. W., Carey, K. D., Dillon, T. J., & Stork, P. A. (1999) · Molecular Endocrinology · doi:10.1210/me.13.1.24 · Cited by 141
Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis
Vezzani, A., & Hoyer, D. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00838.x · Cited by 140
Kreienkamp, H., Larusson, H. J., Witte, I., Roeder, T., İyison, N. B., Hönck, H., Harder, S., Ellinghausen, G., Buck, F., & Richter, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206931200 · Cited by 139
Self-citationSystemic Distribution of Somatostatin Receptor Subtypes in Human: An Immunohistochemical Study
Taniyama, Y., Suzuki, T., Mikami, Y., Moriya, T., Satomi, S., & Sasano, H. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.605 · Cited by 139
Pharmacological properties of two cloned somatostatin receptors.
Rens‐Domiano, S., Law, S. F., Yamada, Y., Seino, S., Bell, G. I., & Reisine, T. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08856-x · Cited by 135
Annamalai, A. K., Webb, A., Kandasamy, N., Elkhawad, M., Moir, S., Khan, F. Z., Maki-Petaja, K. M., Gayton, E. L., Strey, C. H., O’Toole, S. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3072 · Cited by 135
Casar‐Borota, O., Heck, A., Schulz, S., Nesland, J. M., Ramm‐Pettersen, J., Lekva, T., Alafuzoff, I. I., & Bollerslev, J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2145 · Cited by 134
Self-citationPeptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms
Baum, R. P., Kulkarni, H., & Carreras, C. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.01.002 · Cited by 134
van Essen, M., Krenning, E. P., Kam, B. L. R., et al. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0688-7 · Cited by 134
A Structural and Functional Acromegaly Classification
Ramos, D. C., Carmichael, J. D., Cooper, O. B., Bonert, V. S., Gertych, A., Mamelak, A. N., & Melmed, S. K. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2468 · Cited by 133
Self-citationAmino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue
Hammond, P., Wade, A. F., Gwilliam, M. E., et al. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.266 · Cited by 131
Somatostatin Receptor Subtype 5 Regulates Insulin Secretion and Glucose Homeostasis
Strowski, M. Z., Köhler, M. G., Chen, H. Y., Trumbauer, M. E., Li, Z., Szalkowski, D., Gopal-Truter, S., Fisher, J. K., Schaeffer, J. M., Blake, A. D., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2001-0035 · Cited by 130
Somatostatin Signaling in Neuronal Cilia Is Criticalfor Object Recognition Memory
Einstein, E. B., Patterson, C. A., Hon, B. J., Regan, K. A., Reddi, J., Melnikoff, D. E., Mateer, M. J., Schulz, S., Johnson, B. N., & Tallent, M. K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5295-09.2010 · Cited by 129
Self-citationLahlou, H., Saint‐Laurent, N., Estève, J., Eychène, A., Pradayrol, L., Pyronnet, S., & Susini, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304524200 · Cited by 126
Dournaud, P., Boudin, H., Schönbrunn, A., Tannenbaum, G. S., & Beaudet, A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-03-01056.1998 · Cited by 125
Self-citationSingh, V., Brendel, M. D., Zacharias, S., Mergler, S., Jahr, H., Wiedenmann, B., Bretzel, R. G., Plöckinger, U., & Strowski, M. Z. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1578 · Cited by 124
Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
de Bruin, C., Pereira, A. M., Feelders, R. A., Romijn, J. A., Roelfsema, F., Sprij-Mooij, D. M., van Aken, M. O., van der Lelij, A., de Herder, W. W., Lamberts, S. W. J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2101 · Cited by 124
Engin, E., Stellbrink, J., Treit, D., & Dickson, C. T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.09.037 · Cited by 123
AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling
Tuominen, I., Heliövaara, E., Raitila, A., Rautiainen, M.-R., Mehine, M. M., Katainen, R., Donner, I., Aittomäki, V., Lehtonen, H. J., Ahlsten, M., et al. (2014) · Oncogene · doi:10.1038/onc.2014.50 · Cited by 122
Kumar, U., Laird, D. W., Srikant, C. B., Escher, E., & Patel, Y. (1997) · Endocrinology · doi:10.1210/endo.138.10.5566 · Cited by 122
Buscail, L., Bournet, B., Vernejoul, F., Cambois, G., Lulka, H., Hanoun, N., Dufresne, M., Meulle, A., Vignolle‐Vidoni, A., Ligat, L., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.1 · Cited by 122
Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm
Barbieri, F., Bajetto, A., Pattarozzi, A., Gatti, M., Würth, R., Thellung, S., Corsaro, A., Villa, V., Nizzari, M., & Florio, T. (2013) · International Journal of Peptides · doi:10.1155/2013/926295 · Cited by 121
Samson, W. K., Zhang, J. V., Avsian-Kretchmer, O., Cui, K., Yosten, G. L. C., Klein, C., Lyu, R., Wang, Y. X., Chen, X. Q., Yang, J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804784200 · Cited by 121
Gromada, J., Høy, M., Buschard, K., Salehi, A., & Rorsman, P. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00519.x · Cited by 120
Benali, N. L., Cordelier, P., Calise, D., Pagès, P., Rochaix, P., Nagy, A., Estève, J., Pour, P. M., Schally, A. V., Vaysse, N., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130196697 · Cited by 120
Maiza, J. C., Vezzosi, D., Matta, M., Donadille, F., Loubes-Lacroix, F., Cournot, M., Bennet, A., & Caron, P. J. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02878.x · Cited by 120
Bertherat, J. Y., Tenenbaum, F., Perlemoine, K., Videau, C., Alberini, J., Richard, B., Dousset, B. E., BERTAGNA, X. Y., & Epelbaum, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021895 · Cited by 120
Reynaert, H. (2004) · Gut · doi:10.1136/gut.2003.036053 · Cited by 119
Fougner, S. L., Casar‐Borota, O., Berg, J. P., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03065.x · Cited by 118
Fischer, T., Doll, C., Jacobs, S., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1063 · Cited by 117
Cescato, R., Érchegyi, J., Waser, B., Piccand, V., Maëcke, H. R., Rivier, J., & Reubi, J. C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701618q · Cited by 116
Viollet, C., Vaillend, C., Videau, C., Bluet‐Pajot, M., Ungerer, A., L’Héritier, A., Kopp, C., Potier, B., Billard, J., Schaeffer, J. M., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00249.x · Cited by 116
Bousquet, C., Delesque, N., Lopez, F., Saint‐Laurent, N., Estève, J., Bedecs, K., Buscail, L., Vaysse, N., & Susini, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.7099 · Cited by 115
Self-citationP�rez, J., Rigo, M., Kaupmann, K., Bruns, C., Yasuda, K., Bell, G. I., L�bbert, H., & Hoyer, D. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169831 · Cited by 115
Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors
Qian, Z. R., Li, T., Ter‐Minassian, M., Yang, J., Chan, J. A.-W., Brais, L. K., Masugi, Y., Thiaglingam, A., Brooks, N. V., Nishihara, R., et al. (2016) · Pancreas · doi:10.1097/mpa.0000000000000700 · Cited by 114
Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease
González‐Rey, E., Varela, N., Sheibanie, A. F., Chorny, A., Ganea, D., & Delgado, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508997103 · Cited by 111
Kumar, U., Grigorakis, S., Watt, H. L., Sasi, R., Snell, L., Watson, P. H., & Chaudhari, S. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-2414-0 · Cited by 110
Cited by
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16177 · Cited by 392
Self-citationClinical Biology of the Pituitary Adenoma
Melmed, S., Kaiser, U. B., Lopes, M. B., Bertherat, J., Syro, L. V., Raverot, G., Reincke, M., Johannsson, G., Beckers, A., Fleseriu, M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac010 · Cited by 321
Self-citationSomatostatin Analogs in Clinical Practice: A Review
Gomes-Porras, M., Cárdenas-Salas, J., & Álvarez-Escolá, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051682 · Cited by 264
Klomp, M. J., Dalm, S. U., de Jong, M., Feelders, R. A., Hofland, J., & Hofland, L. J. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09607-z · Cited by 69
Radiolabeled somatostatin analogs-a continuously evolving class of radiopharmaceuticals.
Fani, M., Mansi, R., Nicolas, G. P., & Wild, D. (2022) · Cancers · doi:10.3390/cancers14051172 · Cited by 56
Metadata
- Authors
- Günther, T., Tulipano, G., Dournaud, P., Bousquet, C., Csaba, Z., Kreienkamp, H.-J., Lupp, A., Korbonits, M., Castaño, J. P., Wester, H.-J., Culler, M., Melmed, S., & Schulz, S.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 70
- Issue
- 4
- Pages
- 763-835
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2889994902
- Cited by
- 253
- References
- 531
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.